ClinicalTrials.gg
Not yet recruitingNCT07430826BONDSUpdated Mar 3, 2026

Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa

An interventional study of Friendship Bench and Infant and Young Child Feeding (IYCF) Curriculum in Neurodevelopment and Child Growth, sponsored by University of Washington. Not yet recruiting. Open to female participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-03.

Sponsored by University of Washington · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
1,260
Allocation
Randomized
Ages
15 Years and older
Sex
Female
01

Study summary

The goal of this randomized controlled trial is to adapt and test a package of interventions to provide nurturing care for children aged 0-2 years in three countries (Botswana, Kenya, Zimbabwe). Mothers living with and without HIV will be enrolled in pregnancy, and their children will be followed for two years. The main objectives of this study are to:

  • Determine whether the adapted package of interventions improves neurodevelopment among children with and without in utero HIV exposure
  • Identify why the intervention does or does not impact children's neurodevelopment.

Researchers will compare children who receive the intervention package and those who do not to see if the interventions improve child neurodevelopment and growth. Researchers will also compare children with and without HIV exposure to see if there are improvements in neurodevelopment and growth for children who were exposed to HIV.

All participants will attend regular prenatal and postnatal care appointments. Participants who are randomized to receive the package of interventions will attend regularly scheduled visits where they will discuss problem-solving strategies, receive information on healthy foods for children, and learn about how to play with their children. Mothers receiving the intervention package will also have the opportunity to meet with other mothers and babies in small groups where their children can play together.

Read the detailed description

Prior to enrollment for the clinical trial, the three interventions will be culturally adapted and refined in Botswana and Kenya using a user-centered co-design approach. A 3-day participatory workshop will be held to select appropriate adaptations to the three interventions while maintaining core components. Following these adaptations, \~80 pregnant women/mother-infant pairs will be recruited for a formative pilot to further refine the three interventions. The workshop and pilot activities have already been completed in Zimbabwe under a different protocol.

Following the clinical trial, we will determine how the package of interventions works (or if it does not work, why) to improve child development. Hypothesized causal biological and behavioral pathways include maternal health, including mental health; infant health and nutrition; caregiving quality; and maternal-child interactions. Throughout the clinical trial, both quantitative and qualitative data will be collected to identify determinants of implementation, acceptability, feasibility, appropriateness, and cost of incorporating the intervention package and neurodevelopmental evaluations into regular maternal and child health services across the three countries. Costing data will also be collected from time and motion cards and study budget records to determine the incremental costs of incorporating the intervention package and neurodevelopmental evaluations in the three participating countries.

02

Conditions studied

  • Neurodevelopment
  • Child Growth

Keywords

  • Nurturing Care Framework
  • CHEU
  • CHU
  • Neurodevelopment
  • Malawi Developmental Assessment Tool
  • HIV
  • vocabulary acquisition
  • functional difficulties
  • Breastfeeding duration
  • Breastfeeding initiation
  • Maternal mental health
  • stunting
  • wasting
  • underweight
03

In context

Growth Disorders

227 studies on the registry are indexed under Growth Disorders; 25 are open to participants now.

This study's planned enrollment of 1,260 is above the median of 413 across 143 interventional studies indexed under Growth Disorders.

Browse Growth Disorders studies →

Lead sponsor

University of Washington is the lead sponsor of 1,433 studies on the registry; 225 are open to participants now.

Of its 158 completed or terminated interventional studies of FDA-regulated products, 136 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant woman attending participating clinics
  • ≥15 years of age
  • Willing to disclose a known positive status or undergo HIV testing if serostatus is unknown or negative
  • Willing to attend follow up visits
  • Resides inside of the study catchment area and does not plan to move within the next 2 years

Exclusion criteria

Exclusion Criteria:

  • Incarcerated individuals
  • Pregnant women and mothers who participated in the Aim 1 pilot of the BONDS interventions or has previously participated in the BONDS interventions during the trial
  • Any pregnant women and mothers who live in a home in which a BONDS participant has already been enrolled
  • Pregnant women, mothers, and babies who have any acute or chronic condition which, in the opinion of the study team, means enrollment in the trial would not be advisable
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
1,260 participants (estimated)

Study arms

  • Experimental
    BONDS Intervention

    The intervention arm will combine three evidence-based interventions (Friendship Bench, infant and young child feeding curriculum, play-based learning curriculum) in a country-adapted package delivered by CHWs to participants starting in pregnancy and continuing through a child's second year of life. The intervention will be delivered at home, in the community, in a government clinic, or study clinic in the context of ongoing antenatal care and maternal and child health services for pregnant women, mothers, and children.

    Behavioral: Friendship Bench · Behavioral: Infant and Young Child Feeding (IYCF) Curriculum · Behavioral: Play-Based Curriculum

  • No intervention
    Standard of Care

    The standard of care arm includes regular antenatal care and maternal and child health services. These services across the three countries include recommended antenatal care visits during which maternal/fetal health is assessed, antenatal tests are conducted, nutrition supplements and disease prophylaxis are provided, and basic education on danger signs, breastfeeding and nutrition are provided. Postnatal and infant care include family planning, growth monitoring, immunization, and assessment of child development.

Interventions

  • BehavioralFriendship Bench

    After enrollment, participants randomized to BONDS will be linked to a community health worker (CHW) who will arrange Friendship Bench (FB) sessions. During the sessions, participants identify their current stressors, and work with CHWs to consider solutions and select and implement practical solutions.

  • BehavioralInfant and Young Child Feeding (IYCF) Curriculum

    Community health workers will deliver the infant and young child feeding (IYCF) curriculum between pregnancy and 2 years. Modules in pregnancy will focus on early breastfeeding initiation, exclusive breastfeeding (EBF), how to breastfeed and challenges with breastfeeding. Following birth, modules will reinforce education and support EBF through 6 months and then transition to the introduction of other foods and food preparation demonstrations with continued breastfeeding.

  • BehavioralPlay-Based Curriculum

    This parent-focused, play-based intervention addresses responsive caregiving and opportunities for early learning. The intervention will emphasize the importance of early learning experiences and adopting a growth mindset, with common themes including the use of scaffolding and "serve and return" activities.

06

What researchers measure

Primary outcomes

  1. Total Score on the Malawi Developmental Assessment Tool (MDAT) at 24 months

    MDAT measures social, language, fine motor and gross motor development using 138 direct observations of children's ability in each domain (gross motor: 36 items; fine motor: 36 items; language: 36 items; social: 30 items). A continuous standardized z-score will be derived based on the total number of items passed by the child across all four domains. Mean differences in total MDAT z-score at 24 months will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

Secondary outcomes

  1. Total Score on the Malawi Developmental Assessment Tool (MDAT) at 12 months

    MDAT measures social, language, fine motor and gross motor development using 138 direct observations of children's ability in each domain (gross motor: 36 items; fine motor: 36 items; language: 36 items; social: 30 items). A continuous standardized z-score will be derived based on the total number of items passed by the child across all four domains. Mean differences in total MDAT z-score at 12 months will be compared between the intervention and control arms.

    Time frame: Study midline (child age: 12 months)

  2. Gross Motor Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 24 months

    MDAT measures gross motor development using 36 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 36 items. Mean differences in MDAT gross motor domain z-score at 24 months will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  3. Fine Motor Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 24 months

    MDAT measures fine motor development using 36 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 36 items. Mean differences in MDAT fine motor domain z-score at 24 months will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  4. Social Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 24 months

    MDAT measures social development using 30 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 30 items. Mean differences in MDAT social domain z-score at 24 months will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  5. Language Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 24 months

    MDAT measures language development using 36 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 36 items. Mean differences in MDAT language domain z-score at 24 months will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  6. Composite Scores of the MacArthur Bates Communicative Development Inventories (CDI) Vocabulary Checklist

    The MacArthur Bates CDI uses caregiver-reported assessments of a child's language acquisition. Caregivers are provided a checklist of the \~100 most commonly spoken words in each language that their child speaks. Mean differences in the number of words spoken will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  7. Presence of Functional Difficulties as Assessed by the Washington Group/UNICEF Child Functioning Module (CFM)

    The CFM assess functional difficulties across eight domains (vision, hearing, mobility, dexterity, communication, learning, playing, and controlling behavior), each assessed using 1-3 four-point Likert scales. The proportion of children with at least one functional difficulty across the eight domains will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  8. Weight-for-age z-score (WAZ) at 24 months

    WAZ will be calculated for each child at 24 months. Mean differences in WAZ will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  9. Length-for-age z-score (LAZ) at 24 months

    LAZ will be calculated for each child at 24 months. Mean differences in LAZ will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  10. Weight-for-length z-score (WLZ) at 24 months

    WLZ will be calculated for each child at 24 months. Mean differences in WLZ will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  11. Head circumference-for-age z-score (HCAZ) at 24 months

    HCAZ will be calculated for each child at 24 months. Mean differences in HCAZ will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

Other outcomes

  1. Gross Motor Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 12 months

    MDAT measures gross motor development using 36 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 36 items. Mean differences in MDAT gross motor domain z-score at 12 months will be compared between the intervention and control arms.

    Time frame: Study midline (child age: 12 months)

  2. Fine Motor Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 12 months

    MDAT measures fine motor development using 36 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 36 items. Mean differences in MDAT fine motor domain z-score at 12 months will be compared between the intervention and control arms.

    Time frame: Study midline (child age: 12 months)

  3. Social Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 12 months

    MDAT measures social development using 30 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 30 items. Mean differences in MDAT social domain z-score at 12 months will be compared between the intervention and control arms.

    Time frame: Study midline (child age: 12 months)

  4. Language Domain Score on the Malawi Developmental Assessment Tool (MDAT) at 12 months

    MDAT measures language development using 36 direct observations. A continuous standardized z-score will be will be derived based on the total number of items passed by the child across these 36 items. Mean differences in MDAT language domain z-score at 12 months will be compared between the intervention and control arms.

    Time frame: Study midline (child age: 12 months)

  5. Proportion of children who are stunted

    The proportion of children who are stunted will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  6. Proportion of children who are wasted

    The proportion of children who are wasted will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  7. Proportion of children who are underweight

    The proportion of children who are underweight will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  8. Proportion of mothers with mental distress at 12 months

    Mothers are considered to have mental distress if they have a positive screening for depression and/or anxiety. The proportion of mothers with mental distress will be compared between the intervention and control arms.

    Time frame: Study midline (child age: 12 months)

  9. Proportion of mothers with mental distress at 24 months

    Mothers are considered to have mental distress if they have a positive screening for depression and/or anxiety. The proportion of mothers with mental distress will be compared between the intervention and control arms.

    Time frame: Study endline (child age: 24 months)

  10. Proportion of mothers who did early initiation of breastfeeding

    Early initiation of breastfeeding (defined as mothers who put the baby to the breast within the first hour of birth) will be obtained via maternal self-report. The proportion of women who initiated breastfeeding within one hour of birth will be compared between the intervention and control arms.

    Time frame: First postnatal visit (0-2 weeks after delivery)

  11. Proportion of infants who were exclusively breastfed through six months of age

    Exclusive breastfeeding will be obtained via maternal self-report of breastfeeding through 6-months of age with no introduction of formula or complementary foods. The proportion of children who were exclusively breastfed for six months will be compared between the intervention and control arms.

    Time frame: First postnatal visit (0-2 weeks after delivery) through child age 6 months

  12. Overall breastfeeding duration

    Overall breastfeeding duration will be measured continuously for each child as the number of months they were breastfed. This will be obtained from maternal self-report. Mean differences in the overall duration of breastfeeding will be compared between the intervention and control arms.

    Time frame: First postnatal visit (0-2 weeks after delivery) through study endline (child age: 24 months)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • World Health Organization. Nurturing care for early childhood development: a framework for helping children survive and thrive to transform health and human potential [Internet]. Geneva: World Health Organization; 2018. 55 p. Available from: iris.who.int/handle/10665/272603
  • Wedderburn CJ, Evans C, Yeung S, Gibb DM, Donald KA, Prendergast AJ. Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework. Curr HIV/AIDS Rep. 2019 Dec;16(6):501-513. doi: 10.1007/s11904-019-00459-0. PubMed 31732866 ↗
  • Lu C, Black MM, Richter LM. Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country level. Lancet Glob Health. 2016 Dec;4(12):e916-e922. doi: 10.1016/S2214-109X(16)30266-2. Epub 2016 Oct 4. PubMed 27717632 ↗
  • Evans C, Chasekwa B, Ntozini R, Majo FD, Mutasa K, Tavengwa N, Mutasa B, Mbuya MNN, Smith LE, Stoltzfus RJ, Moulton LH, Humphrey JH, Prendergast AJ; Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team. Mortality, Human Immunodeficiency Virus (HIV) Transmission, and Growth in Children Exposed to HIV in Rural Zimbabwe. Clin Infect Dis. 2021 Feb 16;72(4):586-594. doi: 10.1093/cid/ciaa076. PubMed 31974572 ↗
  • Jeong J, Franchett EE, Ramos de Oliveira CV, Rehmani K, Yousafzai AK. Parenting interventions to promote early child development in the first three years of life: A global systematic review and meta-analysis. PLoS Med. 2021 May 10;18(5):e1003602. doi: 10.1371/journal.pmed.1003602. eCollection 2021 May. PubMed 33970913 ↗
  • Chibanda D, Weiss HA, Verhey R, Simms V, Munjoma R, Rusakaniko S, Chingono A, Munetsi E, Bere T, Manda E, Abas M, Araya R. Effect of a Primary Care-Based Psychological Intervention on Symptoms of Common Mental Disorders in Zimbabwe: A Randomized Clinical Trial. JAMA. 2016 Dec 27;316(24):2618-2626. doi: 10.1001/jama.2016.19102. PubMed 28027368 ↗

Individual participant data

Plan to share: Yes — All IPD that is not directly identifiable will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: IPD will be available on NICHD DASH 12 months after the end of participant follow-up, which is anticipated to be December 2029. Supporting information (protocol, ICFs, SAPs) is anticipated to be available on ct.gov by May 2027.

Access criteria: IPD will be available open access on NICHD DASH. Supporting information will be available open access on ct.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2029, 37 months later.

Of 77 non-industry interventional studies with no phase under Growth Disorders, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 30. This study's planned 37 months is above that.

Counting every sponsor, half of 78 studies reached it within 23 months; a quarter within 12 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2026
First posted
Feb 24, 2026
StartEst.
Nov 2026
Primary completionEst.
Dec 2029
CompletionEst.
Dec 2029
Last update
Mar 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07430826
Responsible party
Grace John-Stewart (Professor: School of Medicine, Global Health, University of Washington) — Principal investigator
First posted
Feb 24, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
Mar 3, 2026

Study contacts

Irene Nyambura Njuguna
Contact
injugun@emory.edu
+1-206-519-1275
Christine McGrath
Contact
mcgrathc@uw.edu
+1 206 619 8700
Grace John-Stewart, Md, PhD
principal investigator · University of Washington
Andrew Prendergast
principal investigator · Queen Mary University of London
Kathleen Powis
principal investigator · Massachusetts General Hospital
Dalton Wamalwa
principal investigator · University of Nairobi / Kenyatta National Hospital
Irene Njuguna
study director · Emory University
Christine McGrath
study director · University of Washington
Andrew Prendergast
study director · Queen Mary University of London
Adam Cassidy
study director · Mayo Clinic

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion